STAMFORD, Conn., Feb. 26, 2018 – FUJIFILM Medical Systems U.S.A., Inc., a leading provider of diagnostic imaging products with a comprehensive portfolio of digital radiography (DR) and women’s health solutions, today announced nine of the initial healthcare systems across the United States which have selected Fujifilm’s ASPIRE Cristalle mammography system with 3D imaging or Digital Breast Tomosynthesis (DBT) option to improve their diagnostic imaging capabilities and women’s health patient outcomes.